Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10002493HBVENSG00000147434.9protein_codingCHRNA6NoNo8973Q15825
TVIS10022746HBVENSG00000147434.9protein_codingCHRNA6NoNo8973Q15825
TVIS10031084HBVENSG00000147434.9protein_codingCHRNA6NoNo8973Q15825
TVIS10050682HBVENSG00000147434.9protein_codingCHRNA6NoNo8973Q15825
TVIS30088685HIVENSG00000147434.9protein_codingCHRNA6NoNo8973Q15825
TVIS30077895HIVENSG00000147434.9protein_codingCHRNA6NoNo8973Q15825
TVIS44009986HTLV-1ENSG00000147434.9protein_codingCHRNA6NoNo8973Q15825
TVIS44032521HTLV-1ENSG00000147434.9protein_codingCHRNA6NoNo8973Q15825
TCGA Plot Options
Drug Information
GeneCHRNA6
DrugBank IDDB01273
Drug NameVarenicline
Target IDBE0003587
UniProt IDQ15825
Regulation Typepartial agonist
PubMed IDs16766716
CitationsMihalak KB, Carroll FI, Luetje CW: Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol. 2006 Sep;70(3):801-5. Epub 2006 Jun 9.
GroupsApproved; Investigational
Direct Classification
SMILESC1C2CNCC1C1=C2C=C2N=CC=NC2=C1
Pathways
PharmGKBPA164781343
ChEMBLCHEMBL1396